Stay updated on EDP-305 Safety and Efficacy in NASH Clinical Trial
Sign up to get notified when there's something new on the EDP-305 Safety and Efficacy in NASH Clinical Trial page.

Latest updates to the EDP-305 Safety and Efficacy in NASH Clinical Trial page
- CheckyesterdayChange DetectedThe page’s footer software revision/version label has been updated from v3.5.2 to v3.5.3, indicating a platform or release update rather than a study-content change.SummaryDifference0.0%

- Check8 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check15 days agoNo Change Detected
- Check23 days agoChange DetectedRemoved the 'Non-alcoholic fatty liver disease' topic and the related 'MedlinePlus Genetics' topic from the page.SummaryDifference0.1%

- Check37 days agoChange DetectedRevision from v3.4.3 to v3.5.0. No visible changes to the study details or navigation.SummaryDifference0.0%

- Check44 days agoChange DetectedThe page revision updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check73 days agoChange DetectedA new site Revision: v3.4.2 tag was added and the previous Revision: v3.4.1 tag was removed. The funding-lapse notice previously displayed has been removed.SummaryDifference0.2%

Stay in the know with updates to EDP-305 Safety and Efficacy in NASH Clinical Trial
Enter your email address, and we'll notify you when there's something new on the EDP-305 Safety and Efficacy in NASH Clinical Trial page.